Traditional cancer care emphasizes surgery, therapy, and pharmacologic interventions, while evidence-based prevention, lifestyle strategies, and supportive care are often siloed or undervalued. From my experience as a breast cancer surgeon and researcher, the most effective care spans early detection, prevention, treatment, and survivorship.
I have witnessed this in my personal life as well. Cancer changed my world. As a young girl, I lost my mother to ovarian cancer and later watched my grandmother face breast cancer, navigating the maze of care focused on the disease, and not the patient. These experiences shaped my mission as a surgeon and researcher.
Living at the intersection of these worlds has shaped my purpose and my work. It fuels my efforts to push the boundaries of what we accept as status quo in the clinic, operating room, c-suite, and globally, by executing the pragmatic application of innovation in science and technology, AI and biomechanics, to impact the lives of women and their families. Today’s healthcare crisis demands creative and agile response, with thought leadership and expertise from clinicians who do not just envision creative tools, but reimagine entire systems of care for a changing landscape.
My approach integrates evidence-based preventive strategies, lifestyle interventions, and supportive care with conventional oncology. These are not alternatives to medicine but complementary tools that improve outcomes, resilience, and survivorship. Prevention is both clinically effective and cost-efficient, and personalized, evidence-guided care can optimize results without being cost prohibitive.
My mission is to foster thoughtful dialogue, practical education, and collaboration across healthcare, industry, and communities, helping rebuild trust and ensure that advances in cancer care are equitable, actionable, and grounded in science. The future of cancer care is one where science leads, prevention is actionable, and care meets patients where they are.
